Ignas D. H.
- Country
- The Netherlands
- Department
- Surgery
Research Overview
- Evaluation of Perioperative Systemic Therapy with Bevacizumab, Folinic Acid, Oxaliplatin, Capecitabine, Fluorouracil, and Irinotecan in Resectable Colorectal Peritoneal Metastases
- Phase II Multicenter Trial of Neoadjuvant Intraperitoneal Irinotecan and Systemic mFOLFOX4-Bevacizumab in Resectable Colorectal Peritoneal Metastases
- Evaluation of Neoadjuvant FOLFIRINOX Versus Gemcitabine-Based Chemoradiotherapy in Borderline Resectable Pancreatic Cancer
Data & Insights
Has run more than one trial at 21 of 45 partner sites.
Specializations
Peritoneal Oncology
Specializes in the treatment of malignant peritoneal mesothelioma, focusing on innovative intraperitoneal therapeutic approaches. Explores advanced treatment methods for patients with peritoneal malignancies.
- Peritoneal Surface Malignancies
- Intraperitoneal Chemotherapy
Colorectal Cancer Treatment
Investigates therapeutic strategies for early rectal cancer, with particular emphasis on organ preservation approaches. Evaluates the effectiveness of various treatment modalities including local excision and chemoradiotherapy.
- Rectal-Preserving Therapy
- Adjuvant Chemoradiotherapy
- Surgical Oncology
Pancreatic Cancer Management
Focuses on treatment strategies for borderline resectable pancreatic cancer, exploring neoadjuvant therapeutic approaches. Evaluates comparative effectiveness of different chemotherapy regimens in pancreatic cancer treatment.
- Neoadjuvant Therapy
- Surgical Resection
- Combined Modality Treatment
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.